<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35033">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01756820</url>
  </required_header>
  <id_info>
    <org_study_id>Ioannina-CTS-HV</org_study_id>
    <nct_id>NCT01756820</nct_id>
  </id_info>
  <brief_title>Single-portal Endoscopic Carpal Tunnel Release Versus Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial</brief_title>
  <acronym>CTS-HV</acronym>
  <official_title>Single-portal Endoscopic Carpal Tunnel Release vs Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ioannina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ioannina</source>
  <oversight_info>
    <authority>Greece: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Single-portal Endoscopic Carpal Tunnel
      Release (Agee technique, SmartRelease™, MicroAire) and mini-open technique (Knifelight®,
      Stryker) are equally effective and safe surgical options for the treatment of primary Carpal
      Tunnel Syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Overall Satisfaction</measure>
    <time_frame>at 1 and 6 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Satisfaction will be assessed by two ways
by answering to the question &quot;are you happy with the result of the surgery?&quot;
with a VAS score (0-100) assessing the satisfaction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>up to 6 months postoperatively</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Any complication will be reported including remaining numbness, pain in incision, painful scar, complex regional pain syndrome, infection etc</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>at 1 and 6 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain will be assessed
as a dichotomous outcome (yes/no)
as a continuous outcome (VAS score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength</measure>
    <time_frame>at 1 and 6 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>key pinch</measure>
    <time_frame>at 1 and 6 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to return to Activities of Daily Living (ADL) and return to work</measure>
    <time_frame>up to the end of the study</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time to return to Activities of Daily Living (ADL) will be reported. Return to work will also be reported for participants that are employed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrences and reoperations</measure>
    <time_frame>up to the end of study</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptom Severity Scale (SSS)</measure>
    <time_frame>at 1 and 6 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function Severity Status (FSS)</measure>
    <time_frame>at 1 and 6 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Carpal Tunnel Syndrome</condition>
  <arm_group>
    <arm_group_label>Single-portal Endoscopic Carpal Tunnel Release (Microaire®)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single-portal Endoscopic Carpal Tunnel Release (Microaire®) will be used, according to the endoscopic technique described by Agee at al.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Knifelight®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A mini-open technique will be performed, using the Knifelight® (Stryker).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single-portal Endoscopic Carpal Tunnel Release (Microaire®)</intervention_name>
    <description>SmartRelease® ECTR endoscopic carpal tunnel release system of MicroAire (http://www.microaire.com/products/ectr-endoscopic-carpal-tunnel/smart-release-ctrs/).</description>
    <arm_group_label>Single-portal Endoscopic Carpal Tunnel Release (Microaire®)</arm_group_label>
    <other_name>SmartRelease® ECTR endoscopic carpal tunnel release system of MicroAire.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Knifelight</intervention_name>
    <description>A mini-open single portal technique using the Knifelight® device (Stryker) according to the surgical technique as described by the manufacturer (antegrade approach)</description>
    <arm_group_label>Knifelight®</arm_group_label>
    <other_name>Knifelight®, Stryker</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  primary Carpal Tunnel Syndrome

          -  no symptoms' relief after 3 months of conservative treatment (NSAIDS, Cast, rest)

               -  electrophysiological examination confirms the Carpal Tunnel Syndrome

        Exclusion Criteria:

          -  Secondary Carpal Tunnel Syndrome

          -  Pregnancy

          -  Rheumatoid diseases

          -  Previous trauma at hand or other condition that may effect the anatomy (eg
             infections)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haris S Vasiliadis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Orthopaedics, School of Medicine, University of Ioannina, Greece</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Theodoros Xenakis</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Orthopaedics, School of Medicine, University of Ioannina, Greece</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Grigorios Mitsionis</last_name>
    <role>Study Director</role>
    <affiliation>Department of Orthopaedics, School of Medicine, University of Ioannina, Greece</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Haris S Vasiliadis, MD, PhD</last_name>
    <phone>+306974354545</phone>
    <email>vasiliadismd@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Theodoros Xenakis, Prof MD</last_name>
    <phone>+302651008097</phone>
    <email>xebiolab@cc.uoi.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Ioannina</name>
      <address>
        <city>Ioannina</city>
        <zip>45500</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haris S Vasiliadis, MD</last_name>
      <phone>+306974354545</phone>
      <email>vasiliadismd@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Theodoros Xenakis, Prof</last_name>
      <email>xebiolab@cc.uoi.gr</email>
    </contact_backup>
    <investigator>
      <last_name>Haris S Vasiliadis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 7, 2014</lastchanged_date>
  <firstreceived_date>December 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ioannina</investigator_affiliation>
    <investigator_full_name>Haris S Vasiliadis, MD, PhD</investigator_full_name>
    <investigator_title>Lecturer in Orthopaedics</investigator_title>
  </responsible_party>
  <keyword>Carpal Tunnel Syndrome</keyword>
  <keyword>transverse ligament</keyword>
  <keyword>carpal tunnel release</keyword>
  <keyword>endoscopic</keyword>
  <keyword>minimal invasive</keyword>
  <keyword>mini-open</keyword>
  <keyword>median nerve</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
